Lacopsy 50mg Tablet contains lacosamide, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing without affecting normal neuronal excitability. This mechanism contributes to its efficacy in reducing seizure frequency. Lacopsy is administered orally, with a recommended starting dose typically of 50 mg twice daily, which may be adjusted based on clinical response and tolerability, up to a maximum dose as prescribed by a healthcare professional. It is important to adhere to prescribed dosing schedules to maintain therapeutic plasma concentrations. Common adverse effects include dizziness, headache, nausea, and fatigue, though serious side effects such as cardiac conduction abnormalities may occur, necessitating monitoring in patients with pre-existing cardiac conditions. Lacopsy should be used cautiously in patients with hepatic or renal impairment, and potential drug interactions should be assessed prior to initiation. This medication is contraindicated in individuals with hypersensitivity to lacosamide or any of its excipients. Regular follow-up and seizure monitoring are essential to optimize treatment outcomes and ensure patient safety.